JEMPERLI: payments to doctors
Payments that named JEMPERLI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.9M
- Providers
- 8,320
- Transactions
- 29,335
- Average per transaction
- $167
The per-transaction average — $167 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,320 providers the average total is $589, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| GSK | $4,904,418 | 100.0% |